PG vs PRLD · P/E 25, rev $84.28B vs rev $6.5M
Procter & Gamble Company (PG) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
PG currently screens at market cap $373.53B and trailing P/E 25.3. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the PG and PRLD stock pages for the full models.
Not investment advice.